Back to Search
Estrostep Fe
by Endo Operations LtdContraceptionCOCP
DiscontinuedReference Drug

Estrogen

Ethinyl Estradiol

0.03Mg

Progestin

Norethindrone Acetate

1.5Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

Moderate

Approval Date

10/9/1996

Additives
ferrous fumarate
Inactive Ingredients
lactosecalcium stearatemicrocrystalline cellulosestarch

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Aurobindo Pharma Limited

Aurovela 1.5/30

Aurobindo Pharma Ltd

Aurovela Fe 1.5/30

Lupin Pharmaceuticals, Inc.

Blisovi Fe 1.5/30

Glenmark Pharmaceuticals Inc., USA

Hailey 1.5/30
Hailey Fe 1.5/30

Barr Laboratories Inc

Junel 1.5/30
Junel Fe 1.5/30

Northstar Rx LLC

Larin 1.5/30
Larin Fe 1.5/30

Xiromed Llc

Norethindrone Acetate And Ethinyl Estradiol
Norethindrone Acetate And Ethinyl Estradiol

Have clinical questions about Estrostep Fe?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy